Insider Selling: Tina Blasi Sells 10,775 Shares of Magellan Health Services Stock (MGLN)
Magellan Health Services (NASDAQ:MGLN) CEO Tina Blasi sold 10,775 shares of the stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $62.07, for a total value of $668,804.25. Following the sale, the chief executive officer now directly owns 8,353 shares of the company’s stock, valued at approximately $518,471. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Shares of Magellan Health Services (NASDAQ:MGLN) traded up 1.22% during mid-day trading on Wednesday, hitting $63.06. 361,567 shares of the company’s stock traded hands. Magellan Health Services has a 1-year low of $53.01 and a 1-year high of $62.62. The stock’s 50-day moving average is $59.25 and its 200-day moving average is $58.93. The company has a market cap of $1.738 billion and a price-to-earnings ratio of 14.04.
Magellan Health Services (NASDAQ:MGLN) last announced its earnings results on Tuesday, April 29th. The company reported $0.92 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.75 by $0.17. The company had revenue of $966.50 million for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter last year, the company posted $1.01 earnings per share. Magellan Health Services’s revenue was up 17.6% compared to the same quarter last year. Analysts expect that Magellan Health Services will post $2.40 EPS for the current fiscal year.
A number of analysts have recently weighed in on MGLN shares. Analysts at TheStreet upgraded shares of Magellan Health Services from a “hold” rating to a “buy” rating in a research note on Monday. Separately, analysts at Jefferies Group raised their price target on shares of Magellan Health Services from $56.00 to $58.00 in a research note on Wednesday, April 30th. They now have a “hold” rating on the stock. Finally, analysts at Ned Davis Research upgraded shares of Magellan Health Services from a “neutral” rating to a “buy” rating in a research note on Monday, April 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. Magellan Health Services currently has a consensus rating of “Hold” and a consensus target price of $60.82.
Magellan Health Services Inc, is engaged in the specialty managed healthcare business. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.